Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at blinatumomab for acute lymphoblastic leukaemia (ALL)

Overview

Cancer types:

Acute leukaemia, Acute lymphoblastic leukaemia (ALL), All cancer types, Blood cancers, Leukaemia

Status:

Results

Phase:

Phase 2

Details

This trial used blinatumomab to reduce the small number of leukaemia cells left in the blood after treatment for B cell acute lymphoblastic leukaemia.

This trial was open for people to join between 2010 and 2013. The researchers published the results in 2018.

Recruitment start: 1 December 2010

Recruitment end: 20 December 2013

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Adele Fielding

Supported by

Amgen

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Last reviewed: 8 August 2019

CRUK internal database number: 8795

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.